Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,664.00    -4.00 (-0.24%)
Bid:
1,662.00
Ask:
1,668.00
Spread: 6.00 (0.361%)
Market Cap: £490.08m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Director/PDMR Shareholding

29 Nov 2022 14:00

RNS Number : 9679H
Avon Protection PLC
29 November 2022
 

29 November 2022

Avon Protection plc ("the Company")

PDMRs' Interest in Shares

Release of 2020 deferred bonus shares

As previously announced to shareholders on 8 December 2020, a portion of the annual bonus payments due to PDMRs Miles Ingrey-Counter and James Wilcox in respect of the 2020 financial year were deferred into Company shares, to be held for two years.

On 25 November 2022, following expiry of the deferral period, 359 deferred bonus shares were released to Miles Ingrey-Counter and 456 to James Wilcox.

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Miles Ingrey-Counter

2) James Wilcox

2

Reason for the notification

a)

Position / status

1) Company Secretary

2) Chief Technical Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Shares released under the 2020 deferred bonus scheme. The shares were purchased on 7 December 2020 for £40.04 and were released following expiry of the 2020 deferral period on 22 November 2022.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Nil

2) Nil

 

1) 359

2) 456

 

d)

Aggregated Information

Aggregated volume

Aggregated price

Aggregated total

 

 

 

815

Nil

Nil

e)

Date of the

transactions

All occurred on 25 November 2022.

 

f)

Place of the

transaction

Outside of a trading venue.

 

 

 

 2022 deferred bonus arrangements

 

A portion of the annual bonus payments due to the Executive Director Rich Cashin and certain PDMRs of the Company in respect of the 2022 financial year were deferred into Company shares on the 25 November 2022. 25% of the annual bonus for the Executive Director, and 25% of the annual bonus linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subject to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

 

The table below sets out the number of 2022 deferred bonus shares held by the Executive Director and each PDMR following this transaction.

 

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Rich Cashin

2) Miles Ingrey-Counter

3) James Wilcox

4) Steve Genzer

2

Reason for the notification

a)

Position / status

1) Chief Financial Officer

2) Company Secretary

3) Chief Technical Officer

4) Chief Operating Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Acquisition of shares. 25% of the annual bonus payments for Executive Directors and 25% of the annual bonus payments linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subjected to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) 11.73

2) 11.73

3) 11.73

4) 11.73

1) 1,185

2) 800

3) 849

4) 1,321

 

d)

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A

e)

Date of the

transactions

All occurred on 2022-11-25

 

f)

Place of the

transaction

London Stock Exchange (XLON)

 

 

LEI: 213800JM1AN62REBWA71Classification: Transactions by PDMRs under article 19 of the Market Abuse Regulation.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXKLFLLFLEFBZ
Date   Source Headline
8th Dec 20084:27 pmRNSDirector/PDMR Shareholding
3rd Dec 20088:40 amRNSDirector/PDMR Shareholding
1st Dec 20084:09 pmRNSDirector/PDMR Shareholding
28th Nov 200810:28 amRNSDirector/PDMR Shareholding
27th Nov 20086:05 pmRNSDirector/PDMR Shareholding
27th Nov 20085:50 pmRNSDirector/PDMR Shareholding
27th Nov 20085:40 pmRNSDirector/PDMR Shareholding
27th Nov 20085:35 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSFinal Results
19th Nov 200812:00 pmRNSNotice of Results
10th Nov 200812:15 pmRNSSale of UK Mixing Facility
23rd Oct 20089:34 amRNSReplacement for Period End Update
23rd Oct 20087:00 amRNSPeriod End Update
28th Aug 20087:00 amRNSContract Win
13th Aug 20083:21 pmRNSBlocklisting Interim Review
8th Aug 20087:00 amRNSInterim Management Statement
17th Jul 20089:33 amRNSDirector/PDMR Shareholding
30th Jun 200811:08 amRNSDirector/PDMR Shareholding
23rd Jun 20089:11 amRNSBoard and Senior Management A
2nd Jun 20082:11 pmRNSDirector/PDMR Shareholding
28th May 20087:00 amRNSInterim Results
19th May 20089:00 amRNSNotice of Results
19th May 20087:00 amRNSContract Award
2nd May 20082:45 pmRNSDirector/PDMR Shareholding
21st Apr 20087:00 amRNSTrading Update
4th Mar 20082:15 pmRNSCompletion of Disposal
18th Feb 20083:47 pmRNSDirector/PDMR Shareholding
8th Feb 20082:38 pmRNSDirector/PDMR Shareholding
8th Feb 20087:00 amRNSDisposal
29th Jan 20082:08 pmRNSDirector/PDMR Shareholding
24th Jan 20084:53 pmRNSAnnual Information Update
24th Jan 20083:07 pmRNSResult of AGM
24th Jan 20082:41 pmRNSDirector/PDMR Shareholding
23rd Jan 200810:30 amRNSAGM Statement
14th Jan 20083:41 pmRNSHolding(s) in Company
11th Jan 20082:12 pmRNSDirector/PDMR Shareholding
9th Jan 20085:05 pmRNSHolding(s) in Company
7th Jan 20082:51 pmRNSTotal Voting Rights
3rd Jan 20083:50 pmRNSHolding(s) in Company
20th Dec 20072:48 pmRNSDirector/PDMR Shareholding
20th Dec 200712:00 pmRNSAnnual Report & Accounts
4th Dec 200712:19 pmRNSTotal Voting Rights
29th Nov 20077:01 amRNSFinal Results
16th Nov 200712:09 pmRNSBlocklisting Interim Review
13th Nov 200712:30 pmRNSTotal Voting Rights
30th Oct 20077:01 amRNSNotice of Results
17th Oct 20073:27 pmRNSHolding(s) in Company
17th Oct 20077:00 amRNSViking Z Seven Approval
8th Oct 20071:33 pmRNSUK Mixing Operation
5th Oct 20077:00 amRNSRe: US JSGPM program

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.